ArticleMolecular therapy. Methods & clinical development2023

A blood-brain barrier-penetrating AAV2 mutant created by a brain microvasculature endothelial cell-targeted AAV2 variant.

Hayato Kawabata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.